Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/7/2025

Clinical Significance of Dilated Right Ventricle with Slightly Dilated Aortic Root and Ascending Aorta

Diagnostic Priorities

  • Unexplained aortic root or ascending aortic dilation should prompt suspicion of an underlying bicuspid aortic valve (BAV), even when valves appear "normal" on initial assessment, according to the American Heart Association 1, 2, 3
  • If transthoracic echocardiography (TTE) is inconclusive for BAV, cardiac MRI, cardiac CTA, or TEE should be used to better visualize the aortic valve morphology, as recommended by the American College of Cardiology 1, 2
  • BAV is present in approximately 1% of the population and is often associated with aortic dilation affecting 20-84% of patients, with prevalence increasing with age, according to the American Heart Association 1, 2

Aortic Measurement and Risk Stratification

  • CT or MRI of the thoracic aorta is indicated when the diameter and morphology of the aortic root and ascending aorta cannot be assessed accurately or completely by TTE, as recommended by the American College of Cardiology 1, 2
  • Measurements should be indexed to body surface area, as absolute diameter measurements may underestimate risk in patients at body size extremes, according to the American Heart Association 4
  • An aortic cross-sectional area (cm²) to height (m) ratio ≥10 cm²/m is considered high-risk and may warrant earlier intervention, as recommended by the American College of Cardiology 5, 4
  • Patients with aortic dilation are at risk for type A aortic dissection, with risk rising significantly when ascending aorta reaches diameters >5.25-5.75 cm, according to the American Heart Association 5

Surveillance and Management

  • For aortic dimensions ≥40 mm (4.0 cm), annual imaging is mandatory regardless of stability, as recommended by the American College of Cardiology 7, 4
  • Patients with BAV require lifelong surveillance imaging of the aorta, even after aortic valve replacement, according to the American Heart Association 1, 2
  • Aggressive blood pressure control is essential if hypertension is present, using any effective antihypertensive agent, as recommended by the American College of Cardiology 7
  • Beta-blockers or angiotensin receptor blockers (ARBs) may be considered for patients with aortic dilation, though evidence for slowing progression in BAV-associated aortopathy is limited, according to the American Heart Association 7, 4

Surgical Thresholds

  • Operative intervention is indicated when ascending aorta diameter reaches ≥55 mm in most patients, as recommended by the American College of Cardiology 5, 9
  • For patients with confirmed BAV, surgery is recommended at ≥50 mm, according to the American Heart Association 5, 9, 7
  • For BAV patients with root phenotype aortopathy (dilation primarily at sinuses of Valsalva), surgery is recommended at ≥50 mm, as recommended by the American College of Cardiology 5, 7